Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 242 | 222 | 240 | 249 | 191 |
| Gross Profit | 242 | 222 | 240 | 249 | 191 |
| Operating Expenses | 703 | 684 | 644 | 676 | 917 |
| Operating Income | -461 | -462 | -404 | -427 | -726 |
| Interest Expense | 17 | 51 | 11 | 16 | 1 |
| Other Income | 0 | 23 | 0 | 0 | 0 |
| Pre-tax Income | -478 | -490 | -415 | -443 | -727 |
| Net Income Continuous | -478 | -490 | -415 | -443 | -727 |
| Net Income | $-478 | $-490 | $-415 | $-443 | $-727 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.02 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.02 | -0.02 | -0.04 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.02 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.02 | -0.02 | -0.04 |
| EBITDA(a) | $-460 | $-461 | $-403 | $-426 | $-723 |